Teva Pharmaceutical Industries Ltd. — Director's Dealing 2023

Oct 18, 2023

Dov Bergwerk � Initial statement of Beneficial Ownership of Securities false

��� ������ ��������� ��"�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	13365
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	18/10/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-096016	Time of broadcast: 14:19 14:19

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onDov Bergwerk � Initial statement of Beneficial Ownership of Securities

Form_3_-_Dov_Bergrwerk-isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 10/10/2023
Address: Dvora Hanevi'a 124 , Tel Aviv 6944020   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: Yael.Ashman@teva.co.il
Previous names of reporting entity:
Name of the Signatory: Kalif Eli Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Dvora Hanevia 124 , Tel Aviv 6944020 Telephone: 03-9148213 Facsimile: E-mail: Yael.Ashman@teva.co.il 1